ArticleDiscover oncology2024

Assessing the predictive role of platelet-lymphocyte ratio in EGFR-mutated non-small cell lung cancer patients treated with tyrosine kinase inhibitors: an analysis across TKI generations.

Ryan Cooper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.